Cell MedX Corp. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cell MedX Corp. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2024.
  • Cell MedX Corp. Common Stock, Shares, Issued for the quarter ending August 31, 2024 was 297M shares, a 372% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 297M +234M +372% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 297M +234M +372% May 31, 2024 10-Q 2024-10-15
Q1 2024 295M +232M +368% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 62.9M 0 0% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 62.9M 0 0% Aug 31, 2023 10-Q 2023-10-16
Q2 2023 62.9M 0 0% May 31, 2023 10-K 2024-08-29
Q1 2023 62.9M 0 0% Feb 28, 2023 10-Q 2023-06-29
Q4 2022 62.9M 0 0% Nov 30, 2022 10-Q 2023-05-19
Q3 2022 62.9M 0 0% Aug 31, 2022 10-Q 2023-04-19
Q2 2022 62.9M +850K +1.37% May 31, 2022 10-K 2023-09-01
Q1 2022 62.9M +3.53M +5.95% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 62.9M +3.53M +5.95% Nov 30, 2021 10-Q 2022-01-12
Q3 2021 62.9M +3.53M +5.95% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 62.1M +6.16M +11% May 31, 2021 10-K 2023-04-07
Q1 2021 59.4M +3.57M +6.4% Feb 28, 2021 10-Q 2021-04-09
Q4 2020 59.4M +3.57M +6.4% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 59.4M +11.1M +22.9% Aug 31, 2020 10-Q 2020-10-15
Q2 2020 55.9M +11.6M +26.3% May 31, 2020 10-Q 2021-04-09
Q1 2020 55.8M +11.5M +26% Feb 29, 2020 10-Q 2020-04-14
Q4 2019 55.8M +11.5M +26% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 48.3M +4.05M +9.15% Aug 31, 2019 10-Q 2019-10-15
Q2 2019 44.3M 0 0% May 31, 2019 10-K 2020-09-15
Q1 2019 44.3M 0 0% Feb 28, 2019 10-Q 2019-04-22
Q4 2018 44.3M +240K +0.55% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 44.3M +4.04M +10% Aug 31, 2018 10-Q/A 2018-10-16
Q2 2018 44.3M +4.04M +10% May 31, 2018 10-K 2019-09-06
Q1 2018 44.3M +4.04M +10% Feb 28, 2018 10-Q 2018-04-16
Q4 2017 44M +3.8M +9.44% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 40.2M +9.24M +29.8% Aug 31, 2017 10-Q 2017-10-17
Q2 2017 40.2M +9.24M +29.8% May 31, 2017 10-K 2018-09-13
Q1 2017 40.2M +9.24M +29.8% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 40.2M +9.24M +29.8% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 31M 0 0% Aug 31, 2016 10-Q 2016-10-17
Q2 2016 31M 0 0% May 31, 2016 10-K 2017-08-29
Q1 2016 31M 0 0% Feb 29, 2016 10-Q 2016-04-14
Q4 2015 31M 0 0% Nov 30, 2015 10-Q 2016-01-14
Q3 2015 31M 0 0% Aug 31, 2015 10-Q 2015-10-15
Q2 2015 31M 0 0% May 31, 2015 10-K 2016-09-13
Q1 2015 31M 0 0% Feb 28, 2015 10-Q 2015-04-14
Q4 2014 31M 0 0% Nov 30, 2014 10-Q 2015-01-14
Q3 2014 31M 0 0% Aug 31, 2014 10-Q 2014-10-09
Q2 2014 31M 0 0% May 31, 2014 10-K 2015-09-03
Q1 2014 31M 0 0% Feb 28, 2014 10-Q/A 2014-07-17
Q4 2013 31M 0 0% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 31M 0 0% Aug 31, 2013 10-Q 2013-10-03
Q2 2013 31M 0 0% May 31, 2013 10-K 2014-08-26
Q1 2013 31M 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 31M +1M +3.33% Nov 30, 2012 10-Q 2013-01-16
Q3 2012 31M +1M +3.33% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 31M +1M +3.33% May 31, 2012 10-K/A 2014-07-17
Q1 2012 31M Feb 29, 2012 10-Q 2012-04-09
Q4 2011 30M Nov 30, 2011 10-Q 2012-03-02
Q3 2011 30M Aug 31, 2011 10-Q 2011-10-17
Q2 2011 30M May 31, 2011 10-K 2012-10-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.